表紙
市場調査レポート

世界のインフルエンザワクチン市場分析・予測

Influenza Vaccines Market & Forecast - Worldwide Analysis

発行 Renub Research 商品コード 227787
出版日 ページ情報 英文 179 Pages; 140 Figures & 7 Tables
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
世界のインフルエンザワクチン市場分析・予測 Influenza Vaccines Market & Forecast - Worldwide Analysis
出版日: 2014年11月14日 ページ情報: 英文 179 Pages; 140 Figures & 7 Tables
概要

認識の向上、新興諸国における予防接種率の増加、季節性インフルエンザに対する政府の予防接種支援の拡大などは、インフルエンザワクチン市場を活性化する主要な促進因子となっています。季節性インフルエンザワクチン市場は2013年に数十億米ドルの市場規模となりました。同市場は2013年から2019年にかけて二桁の割合で成長すると予測されています。

当レポートでは、世界のインフルエンザワクチン市場の現状と見通しについて調査分析し、市場規模の推移と予測、地域/国・インフルエンザタイプ・主要ワクチンブランドタイプ別の詳細、市場成長への各種推進因子の分析、主要事業者の収益・企業分析などをまとめ、お届けします。

第1章 エグゼクティブサマリー

第2章 世界のインフルエンザワクチン市場・予測

  • 世界:季節性インフルエンザワクチンを接種する人数
  • インフルエンザワクチン市場におけるM&A

第3章 世界:季節性インフルエンザワクチン市場・予測

第4章 世界:豚(H1N1)インフルエンザワクチン市場

第5章 世界のインフルエンザワクチン市場シェア・予測

  • セグメント別:インフルエンザワクチン市場シェア・予測
  • 国別:季節性インフルエンザワクチンを接種する人数の割合、シェア・予測
  • 国別:季節性インフルエンザワクチン市場シェア・予測
  • 第6章 地域区分季節性インフルエンザワクチン市場・予防接種率
  • 米国
  • 日本
  • 中国
  • インド
  • ブラジル
  • オランダ
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ポルトガル
  • ルクセンブルグ
  • リトアニア
  • 英国
  • ポーランド
  • ノルウェー
  • ルーマニア
  • エストニア
  • フィンランド
  • ハンガリー
  • アイルランド
  • アイスランド
  • ラトビア
  • マルタ
  • スロバキア
  • スロバニア
  • オーストラリア
  • ニュージーランド

第7章 世界:季節性インフルエンザワクチンブランドの売上・予測

  • Fluarix/Flulaval:売上実績・予測
  • Afluria/Fluvax:売上実績・予測
  • FluMist/Fluenz:売上実績・予測
  • Influvac (Abbottにより買収):売上実績・予測
  • Fluvirin / Flucelvax:売上実績・予測
  • Fluzone:売上実績・予測

第8章 インフルエンザワクチン市場における成長促進因子

  • ワクチン技術の転換
  • 効果的な通信戦略への継続的なフォーカス
  • ワクチンは疾病予防に最もコスト効果的な手段
  • 化学的・技術的な成功
  • 欧州諸国における季節性インフルエンザ・予防接種に関する教育、トレーニングおよび情報交換の推進

第9章 インフルエンザワクチン市場の課題

  • 認可済みワクチンを最大限に活用するにあたっての障害
  • インフルエンザワクチン開発・認可制度の難しさ
  • ワクチン開発スケジュールの短縮
  • 予防接種において医療従事者が直面する問題

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market.

Seasonal Influenza vaccines market has Billions US$ market in 2013. Seasonal Influenza vaccines market is expected to grow with double digit percentage from 2013 to 2019. On the other hand, H1N1 Influenza vaccines market has seen tremendous growth during 2009 and 2010 primarily driven by the global spread of H1N1 Influenza virus. However, strong demand of Influenza vaccines contracted in 2011 by more than 50% due to waning threat of swine flu epidemic.

United States remains the largest market for Seasonal Influenza vaccines. Japan and emerging countries like China, India and Brazil is likely to drive Influenza vaccines markets in the next 5 to 6 years. Netherlands and United Kingdom have achieved greater vaccinations coverage.

In the major Seasonal Influenza vaccines sales segment, Fluzone (Sanofi Pasteur) has the highest sales figures and likely to maintain leadership position in the Seasonal Influenza vaccines market.

This is 2nd edition report on Influenza Vaccines by Renub Research. Research study titled "Influenza Vaccines Market & Forecast - Worldwide Analysis" provides a comprehensive assessment of the fast-evolving, high-growth of World Influenza Vaccines landscape. This 179 page report with 140 Figures and 7 Tables examines the following segments for Influenza Vaccines Market

  • Worldwide Influenza vaccines market (2009 - 2019)
  • Worldwide Seasonal Influenza vaccines market has been covered from (2009 - 2019)
  • Worldwide Swine Flu (H1N1) Influenza vaccines market has been covered from (2009 - 2011)
  • Worldwide number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
  • Top 30 countries number of persons being vaccinated with Seasonal Influenza vaccines (2009 - 2019)
  • Top 30 countries Seasonal Influenza vaccines market (2008 - 2019)
  • Top Brands Seasonal Influenza vaccines (Fluarix/Flulaval, Afluria/Fluvax, FluMist/Fluenz, Influvac, Fluvirin / Flucelvax, Fluzone) Sales Performance & Forecast
  • Top Merger & Acquisition deals in Influenza Vaccines Market
  • Key drivers of growth in the Worldwide Influenza Vaccines Market
  • Key challenges faces by Influenza Vaccines Market

All the 30 Countries Studied in the Report are as Follows

  • 1. United States
  • 2. Japan
  • 3. China
  • 4. India
  • 5. Brazil
  • 6. Netherlands
  • 7. Germany
  • 8. France
  • 9. Italy
  • 10. Spain
  • 11. Denmark
  • 12. Sweden
  • 13. Portugal
  • 14. Luxembourg
  • 15. Lithuania
  • 16. United Kingdom
  • 17. Poland
  • 18. Norway
  • 19. Romania
  • 20. Estonia
  • 21. Finland
  • 22. Hungary
  • 23. Ireland
  • 24. Iceland
  • 25. Latvia
  • 26. Malta
  • 27. Slovakia
  • 28. Slovenia
  • 29. Australia
  • 30. New Zealand

Top 6 Seasonal Influenza Vaccines Sales Performance Studied in the Report are as Follows

  • 1. Fluarix / Flulaval
  • 2. Afluria/Fluvax
  • 3. FluMist/Fluenz
  • 4. Influvac
  • 5. Fluvirin / Flucelvax
  • 6. Fluzone
  • Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Influenza Vaccines Market & Forecast

  • 2.1 Worldwide - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
  • 2.2 Merger and Acquisition in Influenza Vaccines Market

3. Worldwide - Seasonal Influenza Vaccines Market & Forecast

4. Worldwide - Swine Flu (H1N1) Influenza Vaccines Market

5. Worldwide Influenza Vaccines Market Share & Forecast

  • 5.1 Segment wise - Influenza Vaccines Market Share & Forecast
  • 5.2 Countries wise - Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share & Forecast
  • 5.3 Countries wise - Seasonal Influenza Vaccines Market Share & Forecast

6. Geographical Segmentation - Seasonal Influenza Vaccines Market & Vaccination Coverage (2008 - 2019)

  • 6.1 United States
    • 6.1.1 United States - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.1.2 United States - Seasonal Influenza Vaccines Market & Forecast
  • 6.2 Japan
    • 6.2.1 Japan - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.2.2 Japan - Seasonal Influenza Vaccines Market & Forecast
  • 6.3 China
    • 6.3.1 China - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.3.2 China - Seasonal Influenza Vaccines Market & Forecast
  • 6.4 India
    • 6.4.1 India - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.4.2 India - Seasonal Influenza Vaccines Market & Forecast
  • 6.5 Brazil
    • 6.5.1 Brazil - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.5.2 Brazil - Seasonal Influenza Vaccines Market & Forecast
  • 6.6 Netherlands
    • 6.6.1 Netherlands - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.6.2 Netherlands - Seasonal Influenza Vaccines Market & Forecast
  • 6.7 Germany
    • 6.7.1 Germany - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.7.2 Germany - Seasonal Influenza Vaccines Market & Forecast
  • 6.8 France
    • 6.8.1 France - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.8.2 France - Seasonal Influenza Vaccines Market & Forecast
  • 6.9 Italy
    • 6.9.1 Italy - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.9.2 Italy - Seasonal Influenza Vaccines Market & Forecast
  • 6.10 Spain
    • 6.10.1 Spain - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.10.2 Spain - Seasonal Influenza Vaccines Market & Forecast
  • 6.11 Denmark
    • 6.11.1 Denmark - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.11.2 Denmark - Seasonal Influenza Vaccines Market & Forecast
  • 6.12 Sweden
    • 6.12.1 Sweden - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.12.2 Sweden - Seasonal Influenza Vaccines Market & Forecast
  • 6.13 Portugal
    • 6.13.1 Portugal - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.13.2 Portugal - Seasonal Influenza Vaccines Market & Forecast
  • 6.14 Luxembourg
    • 6.14.1 Luxembourg - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.14.2 Luxembourg - Seasonal Influenza Vaccines Market & Forecast
  • 6.15 Lithuania
    • 6.15.1 Lithuania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.15.2 Lithuania - Seasonal Influenza Vaccines Market & Forecast
  • 6.16 United Kingdom
    • 6.16.1 United Kingdom - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.16.2 United Kingdom - Seasonal Influenza Vaccines Market & Forecast
  • 6.17 Poland
    • 6.17.1 Poland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.17.2 Poland - Seasonal Influenza Vaccines Market & Forecast
  • 6.18 Norway
    • 6.18.1 Norway - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.18.2 Norway - Seasonal Influenza Vaccines Market & Forecast
  • 6.19 Romania
    • 6.19.1 Romania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.19.2 Romania - Seasonal Influenza Vaccines Market & Forecast
  • 6.20 Estonia
    • 6.20.1 Estonia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.20.2 Estonia - Seasonal Influenza Vaccines Market & Forecast
  • 6.21 Finland
    • 6.21.1 Finland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.21.2 Finland - Seasonal Influenza Vaccines Market & Forecast
  • 6.22 Hungary
    • 6.22.1 Hungary - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.22.2 Hungary - Seasonal Influenza Vaccines Market & Forecast
  • 6.23 Ireland
    • 6.23.1 Ireland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.23.2 Ireland - Seasonal Influenza Vaccines Market & Forecast
  • 6.24 Iceland
    • 6.24.1 Iceland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.24.2 Iceland - Seasonal Influenza Vaccines Market & Forecast
  • 6.25 Latvia
    • 6.25.1 Latvia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.25.2 Latvia - Seasonal Influenza Vaccines Market & Forecast
  • 6.26 Malta
    • 6.26.1 Malta - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.26.2 Malta - Seasonal Influenza Vaccines Market & Forecast
  • 6.27 Slovakia
    • 6.27.1 Slovakia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.27.2 Slovakia - Seasonal Influenza Vaccines Market & Forecast
  • 6.28 Slovenia
    • 6.28.1 Slovenia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.28.2 Slovenia - Seasonal Influenza Vaccines Market & Forecast
  • 6.29 Australia
    • 6.29.1 Australia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.29.2 Australia - Seasonal Influenza Vaccines Market & Forecast
  • 6.30 New Zealand
    • 6.30.1 New Zealand - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines
    • 6.30.2 New Zealand - Seasonal Influenza Vaccines Market & Forecast

7. Worldwide - Seasonal Influenza Vaccine Brand Sales & Forecast

  • 7.1 Fluarix / Flulaval - Sales Performance & Forecast
  • 7.2 Afluria/Fluvax - Sales Performance & Forecast
  • 7.3 FluMist/Fluenz - Sales Performance & Forecast
  • 7.4 Influvac (Now Acquired by Abbott) - Sales Performance & Forecast
  • 7.5 Fluvirin / Flucelvax - Sales Performance & Forecast
  • 7.6 Fluzone - Sales Performance & Forecast

8. Growth Drivers in the Influenza Vaccines Market

  • 8.1 Transforming Vaccine Technologies
  • 8.2 Continuous Focus on Effective Communication Strategies
  • 8.3 Vaccines most Cost Effective Means of Disease Prevention
  • 8.4 Scientific & Technological Breakthroughs
  • 8.5 Promote Education, Training, & Information exchange on Seasonal Influenza & Vaccination in European Countries

9. Challenges for Influenza Vaccine Market

  • 9.1 Obstacle to Best Possible use of Licensed Vaccines
    • 9.1.1 Economic Obstacles
    • 9.1.2 Technical Obstacles
    • 9.1.3 Cultural Obstacles
  • 9.2 Difficulty of Influenza Vaccine Development & Approval System
    • 9.2.1 General Technical Barriers
    • 9.2.2 Economic Barriers
    • 9.2.3 Legal Barriers
    • 9.2.4 Regulatory Barriers
  • 9.3 Reducing the Timeline for Vaccine Development
  • 9.4 Problem Faced by Healthcare Workers in Immunization

LIST OF FIGURES

  • Figure 2 1: Worldwide - Influenza Vaccines Market (Million US$), 2009 - 2013
  • Figure 2 2: Worldwide - Forecast for Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 2 3: Worldwide - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2009 - 2013
  • Figure 2 4: Worldwide - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Million), 2014 - 2019
  • Figure 3 1: Worldwide - Seasonal Influenza Vaccines Market (Million US$), 2009 - 2013
  • Figure 3 2: Worldwide - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 4 1: Worldwide - Swine Flu (H1N1) Influenza Vaccines Market (Million US$), 2009 - 2011
  • Figure 5 1: Segment wise - Influenza Vaccines Market Share (Percent), 2009 - 2013
  • Figure 5 2: Segment wise - Forecast for Influenza Vaccines Market Share (Percent), 2014 - 2019
  • Figure 6 1: United States - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2009 - 2013
  • Figure 6 2: United States - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 3: United States - Seasonal Influenza Vaccines Market (Million US$), 2009 - 2013
  • Figure 6 4: United States - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 5: Japan - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 6: Japan - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 7: Japan - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 8: Japan - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 9: China - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008-2013
  • Figure 6 10: China - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 11: China - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 12: China - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 13: India - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 14: India - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 15: India - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 16: India - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 17: Brazil - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 18: Brazil - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 19: Brazil - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 20: Brazil - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 21: Netherlands - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 22: Netherlands - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 23: Netherlands - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 24: Netherlands - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 25: Germany - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 26: Germany - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 27: Germany - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 28: Germany - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 29: France - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 30: France - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 31: France - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 32: France - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 33: Italy - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 34: Italy - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 35: Italy - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 36: Italy - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 37: Spain - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 38: Spain - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 39: Spain - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 40: Spain - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 41: Denmark - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 42: Denmark - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 43: Denmark - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 44: Denmark - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 45: Sweden - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 46: Sweden - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 47: Sweden - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 48: Sweden - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 49: Portugal - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 50: Portugal - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 51: Portugal - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 52: Portugal - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 53: Luxembourg - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 54: Luxembourg - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 55: Luxembourg - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 56: Luxembourg - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 57: Lithuania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 58: Lithuania - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 59: Lithuania - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 60: Lithuania - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 61: United Kingdom - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 62: United Kingdom - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 63: United Kingdom - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 64: United Kingdom - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 65: Poland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 66: Poland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 67: Poland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 68: Poland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 69: Norway - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 70: Norway - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 71: Norway - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 72: Norway - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 73: Romania - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 74: Romania - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 75: Romania - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 76: Romania - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 77: Estonia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 78: Estonia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 79: Estonia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 80: Estonia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 81: Finland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 82: Finland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 83: Finland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 84: Finland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 85: Hungary - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 86: Hungary - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 87: Hungary - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 88: Hungary - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 89: Ireland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008-2013
  • Figure 6 90: Ireland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 91: Ireland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 92: Ireland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 93: Iceland - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 94: Iceland - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 95: Iceland - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 96: Iceland - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 97: Latvia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 98: Latvia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 99: Latvia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 100: Latvia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 101: Malta - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 102: Malta - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 103: Malta - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 104: Malta - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 105: Slovakia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 106: Slovakia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 107: Slovakia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 108: Slovakia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 109: Slovenia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 110: Slovenia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 111: Slovenia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 112: Slovenia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 113: Australia - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 114: Australia - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 115: Australia - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 116: Australia - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 6 117: New Zealand - Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2008 - 2013
  • Figure 6 118: New Zealand - Forecast for Number of Persons Being Vaccinated with Seasonal Influenza Vaccines (Thousand), 2014 - 2019
  • Figure 6 119: New Zealand - Seasonal Influenza Vaccines Market (Million US$), 2008 - 2013
  • Figure 6 120: New Zealand - Forecast for Seasonal Influenza Vaccines Market (Million US$), 2014 - 2019
  • Figure 7 1: Worldwide - Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2007 - 2013
  • Figure 7 2: Worldwide - Forecast for Fluarix / Flulaval Seasonal Influenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 3: Worldwide - Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2010 - 2013
  • Figure 7 4: Worldwide - Forecast for Afluria/Fluvax Seasonal Influenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 5: Worldwide - Flumist/ Fluenz Seasonal Infuenza Vaccine Sales (Million US$), 2009 - 2013
  • Figure 7 6: Worldwide - Forecast for Flumist/Fluenz Seasonal Influenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 7: Worldwide - Influvac Seasonal Infuenza Vaccine Sales (Million US$), 2007 - 2009
  • Figure 7 8: Worldwide - Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2010 - 2013
  • Figure 7 9: Worldwide - Forecast for Fluvirin/Flucelvax Seasonal Infuenza Vaccine Sales (Million US$), 2014 - 2019
  • Figure 7 10: Worldwide - Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2009 - 2013
  • Figure 7 11: Worldwide - Forecast for Fluzone Seasonal Infuenza Vaccine Sales (Million US$), 2014 - 2019

LIST OF TABLES

  • Table 2 1: Worldwide - Merger and Acquisition in Influenza Vaccines Market (Million US$), 2005 - 2011
  • Table 5 1: Countries wise - Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2009 - 2013
  • Table 5 2: Countries wise - Forecast for Percentage of Persons Being Vaccinated with Seasonal Influenza Vaccines Share (Percent), 2014 - 2019
  • Table 5 3: Countries wise - Seasonal Influenza Vaccines Market Share (Percent), 2009 - 2013
  • Table 5 4: Countries wise - Forecast for Seasonal Influenza Vaccines Market Share (Percent), 2014 - 2019
  • Table 8 1: Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
  • Table 8 2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Back to Top